Accelero Capital Revenue and Competitors

Location

N/A

Total Funding

Fintech

Industry

Estimated Revenue & Valuation

  • Accelero Capital's estimated annual revenue is currently $936k per year.(i)
  • Accelero Capital's estimated revenue per employee is $78,000

Employee Data

  • Accelero Capital has 12 Employees.(i)
  • Accelero Capital grew their employee count by 20% last year.

Accelero Capital's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.8M27-4%$15.7MN/A
#2
$25.5M178-3%N/AN/A
#3
$1.4M22-50%$21.2MN/A
#4
$56.6M34819%$6MN/A
#5
$6.3M56-21%$216.8MN/A
#6
$0M20%$33.3MN/A
#7
$33.3M2330%N/AN/A
#8
$32.4M232-26%$64.6MN/A
#9
$30M215-22%$46.8MN/A
#10
$261.6M140715%$75MN/A
Add Company

What Is Accelero Capital?

Accelero Capital is an investment and management group focused on telecommunication, digital media and technology. Accelero Capital`s management team has an unparalleled track record in strategic, operational and financial management. It leverages its expertise and sector know-how to identify high-growth assets and assets with turnaround potential.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$936k

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Accelero Capital News

2022-04-13 - Global Aptamers: Therapeutics, Technologies and Services ...

2bind; Accelero Bioanalytics; Achiko; Acuitas Capital; Admera Health; Aju IB; Allergan; Amgen; ASKA Pharmaceutical; AstraZeneca; blueconic...

2022-04-06 - Global Targeted Protein Degradation (TPD) Market ...

... Venture capital financing of TPD technology companies ... AbbVie; Accelero Biostructures; Amgen; Amphista Therapeutics; AnHorn Medicines...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M120%N/A
#2
$1.5M12-40%N/A
#3
$1M12N/AN/A
#4
$1M12N/AN/A
#5
$1M12N/AN/A